Fülöp Vilmos, Vermes Gábor, Demeter János
Magyar Honvédség Egészségügyi Központ, Szülészeti-nőgyógyászati Osztály, Semmelweis Egyetem Gyakorló Kórház Budapest, Podmaniczky u. 111., 1062.
Egészségügyi Kar, Miskolci Egyetem Miskolc.
Orv Hetil. 2019 Aug;160(32):1247-1259. doi: 10.1556/650.2019.31448.
The aim of this review is to explore, in addition to revealing the biological background, new conceptual and therapeutic approaches for reproductive clinicians to provide better and more effective care for sterile and infertile couples. In humans, 75% of unsuccessful pregnancies are the result of failures of implantation, and implantation failure is the limiting factor for fertilization treatment. A modified "good" inflammation is necessary for implantation and parturition, but for most of pregnancy, inflammation threatens the continuation of pregnancy. During this period, maintaining the non-inflammatory condition is extremely important, enabling the maternal epigenetic effects to occur in the fetus, making it possible for the offspring to adapt as much as possible to the extrauterine life. In the maintenance of the non-inflammatory condition of pregnancy, a large amount of progesterone hormone produced by the placenta (after the luteo-placental shift) plays a crucial role. It has been reported that the role of inflammation during implantation is an ancestral response to the embryo as a foreign body. During normal pregnancy, this inflammation is initiated by the trophoblast and involves the suppression of neutrophil infiltration, the recruitment of natural killer cells to the site of implantation as well as the production of a range of proinflammatory cytokines. During the "implantation window", the uterus is primed to produce several inflammatory signals such as prostaglandin E and a range of proinflammatory cytokines, including TNF, IL6 and IFNγ. The feto-placental unit is a semi-foreign graft called a "semi allograft", and the recognition of pregnancy by the mother (host) and the resulting maternal immune tolerance is an essential part of successful pregnancy and the birth of a healthy fetus. Because of the functional or absolute reduction of circulating progesterone (due to the decreasing hormone production of the physiologically "aging" placenta after around the 36th week of pregnancy) progesterone effects become insufficient. Therefore it is unable to suppress the production of IL8 and other inflammatory cytokines and the term inflammation, leading to cervical ripening, uterus contractions and parturition ("good" inflammation). Orv Hetil. 2019; 160(32): 1247-1259.
本综述的目的是,除揭示生物学背景外,探索新的概念和治疗方法,以便生殖临床医生为不孕不育夫妇提供更好、更有效的护理。在人类中,75% 的妊娠失败是着床失败的结果,而着床失败是受精治疗的限制因素。适度的 “良性” 炎症对于着床和分娩是必要的,但在大多数孕期,炎症会威胁到妊娠的持续。在此期间,维持非炎症状态极为重要,这能使母体的表观遗传效应在胎儿身上发生,使后代尽可能适应宫外生活。在维持妊娠的非炎症状态方面,胎盘(黄体 - 胎盘转换后)产生的大量孕酮激素起着关键作用。据报道,着床期间炎症的作用是对作为异物的胚胎的一种原始反应。在正常妊娠期间,这种炎症由滋养层引发,涉及抑制中性粒细胞浸润、将自然杀伤细胞募集到着床部位以及产生一系列促炎细胞因子。在 “着床窗口期”,子宫准备产生多种炎症信号,如前列腺素E和一系列促炎细胞因子,包括肿瘤坏死因子、白细胞介素6和干扰素γ。胎儿 - 胎盘单位是一种被称为 “半同种异体移植” 的半异物移植物,母亲(宿主)对妊娠的识别以及由此产生的母体免疫耐受是成功妊娠和健康胎儿出生的重要组成部分。由于循环孕酮功能或绝对减少(由于妊娠约36周后生理上 “老化” 的胎盘激素分泌减少),孕酮的作用变得不足。因此,它无法抑制白细胞介素8和其他炎症细胞因子的产生以及足月时的炎症,从而导致宫颈成熟、子宫收缩和分娩(“良性” 炎症)。《匈牙利医学周报》。2019年;160(32): 1247 - 1259。